864 related articles for article (PubMed ID: 10878498)
1. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
[TBL] [Abstract][Full Text] [Related]
2. Histaminergic activation of the hypothalamic-pituitary-adrenal axis.
Kjaer A; Larsen PJ; Knigge U; Warberg J
Endocrinology; 1994 Sep; 135(3):1171-7. PubMed ID: 8070360
[TBL] [Abstract][Full Text] [Related]
3. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
4. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
Kent P; Anisman H; Merali Z
Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
6. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
7. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
8. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
[TBL] [Abstract][Full Text] [Related]
9. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice.
Téblick A; De Bruyn L; Van Oudenhove T; Vander Perre S; Pauwels L; Derde S; Langouche L; Van den Berghe G
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34698826
[TBL] [Abstract][Full Text] [Related]
11. Arginine-vasopressin and corticotropin-releasing hormone are sequentially involved in the endothelin-1-induced acute stimulation of rat pituitary-adrenocortical axis.
Malendowicz LK; Belloni AS; Nussdorfer GG; Hochol A; Nowak M
J Steroid Biochem Mol Biol; 1998 Jul; 66(1-2):45-9. PubMed ID: 9712410
[TBL] [Abstract][Full Text] [Related]
12. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
13. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
Stewart LQ; Roper JA; Young WS; O'Carroll AM; Lolait SJ
Psychoneuroendocrinology; 2008 May; 33(4):405-15. PubMed ID: 18243568
[TBL] [Abstract][Full Text] [Related]
14. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
15. Endomorphins and activation of the hypothalamo-pituitary-adrenal axis.
Coventry TL; Jessop DS; Finn DP; Crabb MD; Kinoshita H; Harbuz MS
J Endocrinol; 2001 Apr; 169(1):185-93. PubMed ID: 11250660
[TBL] [Abstract][Full Text] [Related]
16. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.
Grinevich V; Ma XM; Herman JP; Jezova D; Akmayev I; Aguilera G
J Neuroendocrinol; 2001 Aug; 13(8):711-23. PubMed ID: 11489088
[TBL] [Abstract][Full Text] [Related]
17. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
18. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
Makino S; Smith MA; Gold PW
Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
[TBL] [Abstract][Full Text] [Related]
20. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
